Clinical Scorecard: Uncommon Case of Esophageal Squamous Cell Carcinoma Metastasizing to the Pancreas and Stomach

At a Glance

Key Highlights

• Rare metastasis of ESCC to pancreas and stomach.
• Patient underwent radical surgical resection after 37 months disease-free interval.
• Postoperative treatment included immune checkpoint inhibitors and platinum-based chemotherapy.
• Importance of considering rare metastases in differential diagnosis.
• Aggressive surgical resection may be a viable treatment strategy.

Guideline-Based Recommendations

Diagnosis

• Consider imaging studies for new pancreatic lesions in ESCC patients.

Management

• Multidisciplinary approach including surgical resection and systemic therapy.

Monitoring & Follow-up

• Regular imaging surveillance post-treatment for early detection of metastases.

Risks

• Potential for distant metastasis even after prolonged disease-free intervals.

Patient & Prescribing Data

62-year-old male with a history of ESCC and significant comorbidities.

Combination of immune checkpoint inhibitors with platinum-based chemotherapy post-surgery.

Clinical Best Practices

• Conduct thorough imaging for patients with ESCC presenting new abdominal symptoms.
• Utilize a multidisciplinary team for treatment planning in complex cases.

Related Resources & Content

• Esophageal Cancer Statistics
• Pancreatic Metastases Overview